These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 32185578)

  • 1. The IL1RN Mutation Creating the Most-Upstream Premature Stop Codon Is Hypomorphic Because of a Reinitiation of Translation.
    Moriya K; Kadowaki S; Nakano T; Akarcan SE; Kutukculer N; Aksu G; Sasahara Y; Kure S; Ohnishi H; Casanova JL; Puel A; Fukao T
    J Clin Immunol; 2020 May; 40(4):643-645. PubMed ID: 32185578
    [No Abstract]   [Full Text] [Related]  

  • 2. Homozygous IL1RN Mutation in Siblings with Deficiency of Interleukin-1 Receptor Antagonist (DIRA).
    Ziaee V; Youssefian L; Faghankhani M; Jazayeri A; Saeidian AH; Vahidnezhad H; Uitto J
    J Clin Immunol; 2020 May; 40(4):637-642. PubMed ID: 32170523
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonsense mutation-dependent reinitiation of translation in mammalian cells.
    Cohen S; Kramarski L; Levi S; Deshe N; Ben David O; Arbely E
    Nucleic Acids Res; 2019 Jul; 47(12):6330-6338. PubMed ID: 31045216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mutation of IL1RN in the deficiency of interleukin-1 receptor antagonist syndrome: description of two unrelated cases from Brazil.
    Jesus AA; Osman M; Silva CA; Kim PW; Pham TH; Gadina M; Yang B; Bertola DR; Carneiro-Sampaio M; Ferguson PJ; Renshaw BR; Schooley K; Brown M; Al-Dosari A; Al-Alami J; Sims JE; Goldbach-Mansky R; El-Shanti H
    Arthritis Rheum; 2011 Dec; 63(12):4007-17. PubMed ID: 22127713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction to: the IL1RN Mutation Creating the Most-Upstream Premature Stop Codon Is Hypomorphic because of a Reinitiation of Translation.
    Moriya K; Kadowaki S; Nakano T; Akarcan SE; Kutukculer N; Aksu G; Sasahara Y; Kure S; Ohnishi H; Casanova JL; Puel A; Fukao T
    J Clin Immunol; 2020 May; 40(4):646. PubMed ID: 32367426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mutation of interleukin-1 receptor antagonist (IL1RN) in a DIRA patient from Turkey: Diagnosis and treatment.
    Sözeri B; Gerçeker-Türk B; Yıldız-Atıkan B; Mir S; Berdeli A
    Turk J Pediatr; 2018; 60(5):588-592. PubMed ID: 30968643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 receptor antagonist deficiency with a novel mutation; late onset and successful treatment with canakinumab: a case report.
    Ulusoy E; Karaca NE; El-Shanti H; Kilicoglu E; Aksu G; Kutukculer N
    J Med Case Rep; 2015 Jun; 9():145. PubMed ID: 26100510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first reported case of compound heterozygous IL1RN mutations causing deficiency of the interleukin-1 receptor antagonist.
    Stenerson M; Dufendach K; Aksentijevich I; Brady J; Austin J; Reed AM
    Arthritis Rheum; 2011 Dec; 63(12):4018-22. PubMed ID: 21792839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of Interleukin-1 Receptor Antagonist (DIRA): Report of the First Indian Patient and a Novel Deletion Affecting IL1RN.
    Mendonca LO; Malle L; Donovan FX; Chandrasekharappa SC; Montealegre Sanchez GA; Garg M; Tedgard U; Castells M; Saini SS; Dutta S; Goldbach-Mansky R; Suri D; Jesus AA
    J Clin Immunol; 2017 Jul; 37(5):445-451. PubMed ID: 28503715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic recurrent multifocal osteomyelitis and deficiency of interleukin-1-receptor antagonist.
    Sakran W; Shalev SA; Sakran W; Shalev SA; El-Shanti H; Uziel Y; Uziel Y
    Pediatr Infect Dis J; 2013 Jan; 32(1):94. PubMed ID: 23241992
    [No Abstract]   [Full Text] [Related]  

  • 11. Case report: Novel compound heterozygous
    Urbaneja E; Bonet N; Solis-Moruno M; Mensa-Vilaro A; de Landazuri IO; Tormo M; Lara R; Plaza S; Fabregat V; Yagüe J; Casals F; Arostegui JI
    Front Immunol; 2024; 15():1381447. PubMed ID: 38646532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient idling of posttermination ribosomes ready to reinitiate protein synthesis.
    Karamyshev AL; Karamysheva ZN; Yamami T; Ito K; Nakamura Y
    Biochimie; 2004 Dec; 86(12):933-8. PubMed ID: 15667944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that translation reinitiation abrogates nonsense-mediated mRNA decay in mammalian cells.
    Zhang J; Maquat LE
    EMBO J; 1997 Feb; 16(4):826-33. PubMed ID: 9049311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DIRA, DITRA, and new insights into pathways of skin inflammation: what's in a name?
    Cowen EW; Goldbach-Mansky R
    Arch Dermatol; 2012 Mar; 148(3):381-4. PubMed ID: 22431779
    [No Abstract]   [Full Text] [Related]  

  • 15. The NEMO mutation creating the most-upstream premature stop codon is hypomorphic because of a reinitiation of translation.
    Puel A; Reichenbach J; Bustamante J; Ku CL; Feinberg J; Döffinger R; Bonnet M; Filipe-Santos O; de Beaucoudrey L; Durandy A; Horneff G; Novelli F; Wahn V; Smahi A; Israel A; Niehues T; Casanova JL
    Am J Hum Genet; 2006 Apr; 78(4):691-701. PubMed ID: 16532398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On-demand treatment with anakinra: a treatment option for selected TRAPS patients.
    Grimwood C; Despert V; Jeru I; Hentgen V
    Rheumatology (Oxford); 2015 Sep; 54(9):1749-51. PubMed ID: 26078218
    [No Abstract]   [Full Text] [Related]  

  • 17. [The role of interleukin-1 and interleukin-1-receptor antagonist in development of familial mediterranean fever and other autoinflammatory diseases].
    Dzhidoian Z
    Georgian Med News; 2011 May; (194):53-6. PubMed ID: 21685523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profile in TNF receptor-associated periodic syndrome reveals constitutively enhanced pathways and new players in the underlying inflammation.
    Borghini S; Ferrera D; Prigione I; Fiore M; Ferraris C; Mirisola V; Amaro AA; Gueli I; Zammataro L; Gattorno M; Pfeffer U; Ceccherini I
    Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S121-S128. PubMed ID: 27310036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant intestinal microbiota due to IL-1 receptor antagonist deficiency promotes IL-17- and TLR4-dependent arthritis.
    Rogier R; Ederveen THA; Boekhorst J; Wopereis H; Scher JU; Manasson J; Frambach SJCM; Knol J; Garssen J; van der Kraan PM; Koenders MI; van den Berg WB; van Hijum SAFT; Abdollahi-Roodsaz S
    Microbiome; 2017 Jun; 5(1):63. PubMed ID: 28645307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New GATA1 mutation in codon 2 leads to the earliest known premature stop codon in transient myeloproliferative disorder.
    Hoeller S; Bihl MP; Tzankov A; Kuehne T; Potthoff C; Bruder E
    Blood; 2009 Oct; 114(17):3717-8. PubMed ID: 19850750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.